Literature DB >> 17432114

The neuregulin-I/ErbB signaling system in development and disease.

Stefan Britsch1.   

Abstract

Neuregulins (NRGs) comprise a large family of EGF-like signaling molecules involved in cell-cell communication during development and disease. The neuregulin family of ligands has four members: NRG1, NRG2, NRG3, and NRG4. Relatively little is known about the biological functions of the NRG2, 3, and 4 proteins. In contrast, the NRG1 proteins have been demonstrated to play important roles during the development of the nervous system, heart, and mammary glands. For example, NRG1 has essential functions in the development of neural crest cells and some of their major derivatives, like Schwann cells and sympathetic neurons. NRG1 controls the trabeculation of the myocardial musculature and the ductal differentiation of the mammary epithelium. Moreover, there is emerging evidence for the involvement of NRG signals in the development and function of several other organ systems, and in human disease, including breast cancer and schizophrenia. Many different isoforms of the Neuregulin-1 gene are synthesized. Such isoforms differ in their tissue-specific expression patterns and their biological activities, thereby contributing to the great diversity of the in vivo functions of NRG1. Neuregulins transmit their signals to target cells by interacting with transmembrane tyrosine kinase receptors of the ErbB family. This family includes four members, the epidermal growth factor receptor (EGF-R, ErbB1, ErbB2, ErbB3, and ErbB4). Receptor-ligand interaction induces the heterodimerization of receptor monomers, which in turn results in the activation of intracellular signaling cascades and the induction of cellular responses including proliferation, migration, differentiation, and survival or apoptosis. In vivo, functional NRG1 receptors are heterodimers composed of ErbB2 with either an ErbB3, or ErbB4 molecule. The tissue-specific distribution of the different receptor types further contributes to the diversity and specificity of the biological functions of this signaling pathway. It is a typical feature of the Neuregulin-1/ErbB signaling pathway to control sequential steps during the development of a particular organ system. For example, this pathway functions in early precursor proliferation, maturation, as well as in the myelination of Schwann cells. The systematic analysis of genetic models that have been established by the help of conventional as well as conditional gene targeting strategies in mice was instrumental for the uncovering of the multitude of biological functions of this signaling system. In this review the basic biology of the Neuregulin-1/ErbB system and how it relates to the in vivo functions were discussed with special emphasis to transgenic techniques in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17432114

Source DB:  PubMed          Journal:  Adv Anat Embryol Cell Biol        ISSN: 0301-5556            Impact factor:   1.231


  111 in total

1.  A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.

Authors:  Benjamin T Spike; Dannielle D Engle; Jennifer C Lin; Samantha K Cheung; Justin La; Geoffrey M Wahl
Journal:  Cell Stem Cell       Date:  2012-02-03       Impact factor: 24.633

Review 2.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression.

Authors:  Maria E Gómez-Casati; Joshua C Murtie; Carlos Rio; Konstantina Stankovic; M Charles Liberman; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

Review 4.  E3 ubiquitin ligases in ErbB receptor quantity control.

Authors:  Kermit L Carraway
Journal:  Semin Cell Dev Biol       Date:  2010-09-22       Impact factor: 7.727

Review 5.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

6.  Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.

Authors:  Courtney Thaxton; Marga Bott; Barbara Walker; Nicklaus A Sparrow; Stephen Lambert; Cristina Fernandez-Valle
Journal:  Mol Cell Neurosci       Date:  2010-12-21       Impact factor: 4.314

7.  Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation.

Authors:  Paula V Monje; Sayuri Rendon; Gagani Athauda; Margaret Bates; Patrick M Wood; Mary Bartlett Bunge
Journal:  Glia       Date:  2009-07       Impact factor: 7.452

8.  Role of neuregulin-1/ErbB signaling in stem cell therapy for spinal cord injury-induced chronic neuropathic pain.

Authors:  Feng Tao; Qun Li; Su Liu; Haiying Wu; John Skinner; Andres Hurtado; Visar Belegu; Orion Furmanski; Ya Yang; John W McDonald; Roger A Johns
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

9.  Reversible overexpression of bace1-cleaved neuregulin-1 N-terminal fragment induces schizophrenia-like phenotypes in mice.

Authors:  Xiaoyang Luo; Wanxia He; Xiangyou Hu; Riqiang Yan
Journal:  Biol Psychiatry       Date:  2013-10-05       Impact factor: 13.382

10.  Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4.

Authors:  Liesbeth Backx; Berten Ceulemans; Joris Robert Vermeesch; Koen Devriendt; Hilde Van Esch
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.